CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Operating Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹6,291 Cr | ₹4,990 Cr | ₹4,512 Cr | ₹4,249 Cr | ₹3,181 Cr |
What is the latest Operating Profit of CIPLA ?
Year | Operating Profit |
---|---|
Mar2025 | ₹6,291 Cr |
Mar2024 | ₹4,990 Cr |
Mar2023 | ₹4,512 Cr |
Mar2022 | ₹4,249 Cr |
Mar2021 | ₹3,181 Cr |
How is Operating Profit of CIPLA Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹6,291 Cr | 26.07 | |
Mar2024 | ₹4,990 Cr | 10.60 | |
Mar2023 | ₹4,512 Cr | 6.20 | |
Mar2022 | ₹4,249 Cr | 33.57 | |
Mar2021 | ₹3,181 Cr | - |
Compare Operating Profit of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹122,842.1 Cr | 0.3% | 1.2% | -5.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹389,172.0 Cr | -1.2% | -3.6% | -8.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,248.0 Cr | -6.6% | -12.4% | 22.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,793.0 Cr | 0.7% | 9.1% | 7.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,869.0 Cr | 0.4% | -2.8% | -12.7% | Stock Analytics | |
MANKIND PHARMA | ₹100,328.0 Cr | -6.9% | -5.5% | 19.2% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 0.3% |
1.2% |
-5.3% |
SENSEX | -0.6% |
-2.8% |
1.7% |
You may also like the below Video Courses